STAR platform

Marengo Reports Phase 2 Breast Cancer Data at AACR

CAMBRIDGE, Mass., April 17, 2026 Marengo Therapeutics, Inc. announced late-breaking Phase 2 clinical results for its investigational immunotherapy invikafusp...

By cGxPwire Editor
April 20, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

STAR platform

Marengo Reports Phase 2 Breast Cancer Data at AACR